Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Influential Women Features Yudelka Columna, MSW, LCSW, MBA: Multi-Awarded Social Worker Advancing Mental Health Care
EIN Presswire
HACKETTSTOWN, NJ, UNITED STATES, September 2, 2026 /EINPresswire.com/ -- Expanding Culturally Sensitive Mental Health Services for Individuals, Families, and Underserved Communities Through Compassionate Leadership and Community Service...
Alveus Therapeutics Strengthens Executive Leadership Team, Opens Boston office
GlobeNewswire, Inc.
BOSTON and COPENHAGEN, Denmark, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Alveus Therapeutics Inc. (“Alveus”), a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases, today announced two key...
Apeloa Honored with Frost & Sullivan's 2026 Global CDMO Company of the Year Award
GlobeNewswire, Inc.
SHANGHAI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Apeloa Pharmaceutical Co., Ltd. (Apeloa; SZSE: 000739.SZ), a leading contract development and manufacturing organization (CDMO) and technology-driven pharmaceutical manufacturer, announced that it has...
Pioneer Behavioral Health Expands to Illinois, Led by Program Director Joshua McPhail
EIN Presswire
A mental health program has opened in Arlington Heights, built on the same clinical model as Pioneer's Joint Commission-accredited programs in Massachusetts.
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire, Inc.
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to treat and prevent severe allergic reactions, today announced that...
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
GlobeNewswire, Inc.
BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) (“Tango Therapeutics” or the “Company”) today announced that members of the management team are scheduled to participate in a fireside chat at the 2026 Cantor...
The Clinical Group and Mediplex Property Group Announce Strategic Alliance
EIN Presswire
Alliance advances The Clinical Group's healthcare real estate investment platform By leveraging Mediplex Property Group's development expertise HACKENSACK, NJ, UNITED STATES, September 16, 2026 /EINPresswire.com/ -- The Clinical Group and...
Millstone Medical Outsourcing Appoints Matt Weber as Director of Business Development
EIN Presswire
Weber brings 14+ years of MedTech commercial, operational, & program management experience to Millstone's One PO model, helping accelerate OEM device launches.
Aeroflow Health Partners with Fallon Health to Expand DME Access to Commercial and Medicare Members in Massachusetts
GlobeNewswire, Inc.
ASHEVILLE, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health, a technology-enabled healthcare company serving millions of patients annually through its network of medical products and services, announced it has partnered with Fallon Health...
Editas Medicine to Participate in Upcoming Investor Conferences
GlobeNewswire, Inc.
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that management will participate in...
Cabot Corporation to Expand North American Battery Materials Platform Through Modified $50 Million DOE Grant
GlobeNewswire, Inc.
BOSTON, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced a modified $50 million grant from the U.S. Department of Energy’s (DOE) Office of Critical Minerals and Energy Innovation (CMEI) that will support the...
Dr. Scott Kamelle Scholarship for Future Doctors Opens Nationwide to Support Aspiring Medical Professionals
EIN Presswire
MILWAUKEE, WI, UNITED STATES, September 1, 2026 /EINPresswire.com/ -- The Dr. Scott Kamelle Scholarship for Future Doctors announces an opportunity for undergraduate students and qualifying students preparing for university-level medical...
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
GlobeNewswire, Inc.
–4-year data from the Phase 1/2a open-label extension (OLE) studies support the potential disease-modifying effects of zorevunersen– –Improvements in cognition and behavior sustained through 4 years, in addition to durable seizure reductions and a...
CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference
GlobeNewswire, Inc.
PARSIPPANY, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced...
Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
GlobeNewswire, Inc.
Company announcement No. 44 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 35, 2026) Copenhagen, Denmark, August 31, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston
GlobeNewswire, Inc.
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief...
Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
GlobeNewswire, Inc.
EMERYVILLE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients,...
Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
GlobeNewswire, Inc.
CORAL GABLES, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders,...
iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
GlobeNewswire, Inc.
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, today announced that it will...
The Path Establishes Scientific Advisory Board to Guide AI Mental Health Research
EIN Presswire
The board brings together six leading experts in digital mental health, behavioral science, psychiatry, and AI to shape The Path's clinical research program SAN FRANCISCO, CA, UNITED STATES, August 31, 2026 /EINPresswire.com/ -- The Path...
Sign up for:
Massachusetts Healthcare Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.